<DOC>
	<DOC>NCT02579265</DOC>
	<brief_summary>To show the superiority in safety of Smoflipid over Intralipid® as measured by the number of study patients in each treatment group with conjugated bilirubin exceeding 2 mg/dL during the first 28 days of study treatment, confirmed by a second sample collected 7 days after the first sample.</brief_summary>
	<brief_title>Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants</brief_title>
	<detailed_description />
	<mesh_term>Soybean oil, phospholipid emulsion</mesh_term>
	<mesh_term>Parenteral Nutrition Solutions</mesh_term>
	<criteria>Neonates and infants, expected to require parenteral nutrition (PN) for 28 days Postmenstrual age ≥ 24 weeks Birth weight ≥ 750g Gastroschisis, duodenal, jejunal or ileal atresia, volvulus, spontaneous intestinal perforation or necrotizing enterocolitis (Bell's stage 2B or higher) At least 80% of nutritional needs at baseline received by PN Signed and dated informed consent obtained from at least one parent or legal guardian Conjugated bilirubin &gt; 0.6 mg/dL Any known pre, intra or posthepatic complication increasing conjugated bilirubin levels &gt; 0.6, mg/dL during study participation Suspected liver disease or liver damage based on either aspartate aminotransferase (AST), alanine aminotransferase (ALT), or gammaglutamyl transferase (GGT) exceeding 2.5x upper limit of normal range Active bloodstream infection demonstrated by positive blood culture at screening Cystic fibrosis Meconium ileus Serum triglyceride levels &gt; 250 mg/dL Cyanotic congenital heart defect Severe renal failure with serum creatinine &gt; 2.0 mg/dL History of shock requiring vasopressors Anasarca Extracorporeal Membrane Oxygenation (ECMO) Known inborn errors of metabolism Known congenital viral infection Unlikely to survive longer than 28 days Known hypersensitivity to fish, egg, soya or peanut protein or to any of the active substances or excipients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Parenteral nutrition</keyword>
	<keyword>Neonates</keyword>
	<keyword>Infants</keyword>
	<keyword>Lipid emulsions</keyword>
	<keyword>Intravenous</keyword>
</DOC>